Bypass Grafting to Circumflex: Left Internal Thoracic Artery versus Saphenous Vein

Abstract

Background This study aimed to compare the short- and long-term outcomes of saphenous vein grafts (SVGs) and in situ left internal thoracic artery (LITA) grafts to the left circumflex artery (LCX) territory.

Methods This study included 678 patients who underwent LITA-left anterior descending (LAD) + SVG-LCX grafts and 286 patients who underwent right internal thoracic artery (RITA)-LAD + in situ LITA-LCX grafts from January 2002 to December 2020. Short-term and long-term clinical outcomes were compared using inverse probability of treatment weighting adjustment to reduce selection bias.

Results In-hospital mortality was significantly higher for the SVG-LCX group (p = 0.008), whereas deep sternal wound infection was significantly higher in the LITA-LCX group (p = 0.013).

Survival rates at 5 and 10 years were 83.12 and 71.45% in the SVG-LCX group, whereas 75.24 and 65.54% in the LITA-LCX group (log-rank p = 0.114). Rates of freedom from cardiac events at 5 and 10 years were 92.82 and 85.24% in the SVG-LCX group, whereas 94.89 and 89.46% in the LITA-LCX group (log-rank p = 0.179).

Univariate and multivariate logistic regression analysis showed that proximal severe stenosis was significantly protective against graft dysfunction before discharge (odds ratio, 0.43; 95% confidence interval, 0.23–0.81).

Conclusion Deep sternal wound infection was significantly higher for LITA to LCX bypass whereas in-hospital mortality was higher for SVG to LCX. In situ LITA to LCX bypass grafting exhibited similar long-term outcomes with SVG to LCX bypass grafting in adjusted patient cohorts. Proximal severe stenosis of LCX was protective against graft dysfunction.

Keywords

cardiac - coronary artery bypass grafts surgery - CABG - myocardial infarction (includes complications; e.g. - rupture) - off-pump surgery

Data Availability Statement

The data associated with the study are not publicly available but are available from the corresponding author on reasonable request.

Authors' Contribution

G.U., H.M., H.T., and S.M. were involved in study design and data interpretation. All authors critically revised the report, commented on drafts of the manuscript, and approved the final report.

Publication History

Received: 29 November 2021

Accepted: 08 March 2022

Article published online:
11 July 2022

• References

• 1 Goldman S, Zadina K, Moritz T. et al; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004; 44 (11) 2149-2156
• 2 Loop FD, Lytle BW, Cosgrove DM. et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314 (01) 1-6
• 3 Grondin CM, Campeau L, Lespérance J, Enjalbert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 1984; 70 (3 Pt 2): I208-I212
• 4 Gansera B, Schmidtler F, Angelis I, Kiask T, Kemkes BM, Botzenhardt F. Patency of internal thoracic artery compared to vein grafts - postoperative angiographic findings in 1189 symptomatic patients in 12 years. Thorac Cardiovasc Surg 2007; 55 (07) 412-417
• 5 Tsuneyoshi H, Komiya T, Shimamoto T. et al. The second best arterial graft to the left coronary system in off-pump bypass surgery: a propensity analysis of the radial artery with a proximal anastomosis to the ascending aorta versus the right internal thoracic artery. Gen Thorac Cardiovasc Surg 2015; 63 (06) 335-342
• 6 Janiec M, Dimberg A, Nazari Shafti TZ, Lagerqvist B, Lindblom RPF. No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry study. Eur J Cardiothorac Surg 2018; 53 (02) 448-454
• 7 Ohira S, Doi K, Okawa K. et al. Safety and efficacy of sequential left internal thoracic artery grafting to left circumflex area. Ann Thorac Surg 2016; 102 (03) 766-773
• 8 Luthra S, Leiva-Juárez MM, John A, Matuszewski M, Morgan IS, Billing JS. A second arterial conduit to the circumflex circulation significantly improves survival after coronary artery bypass surgery. Eur J Cardiothorac Surg 2018; 53 (02) 455-462
• 9 Thuijs DJFM, Head SJ, Stone GW. et al. Outcomes following surgical revascularization with single versus bilateral internal thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery bypass grafting: insights from the EXCEL trial. Eur J Cardiothorac Surg 2019; 55 (03) 501-510
• 10 Pevni D, Ziv-Baran T, Kramer A, Farkash A, Ben-Gal Y. Is the use of BITA vs SITA grafting safe and beneficial in octogenarians?. Ann Thorac Surg 2021; 111 (06) 1998-2003
• 11 Navia D, Espinoza J, Vrancic M. et al. Bilateral internal thoracic artery grafting in elderly patients: any benefit in survival?. J Thorac Cardiovasc Surg 2022; 164 (02) 542-549
• 12 Magruder JT, Young A, Grimm JC. et al. Bilateral internal thoracic artery grafting: does graft configuration affect outcome?. J Thorac Cardiovasc Surg 2016; 152 (01) 120-127
• 13 Bakaeen FG, Ghandour H, Ravichandren K. et al. Right internal thoracic artery patency is affected more by target choice than conduit configuration. Ann Thorac Surg 2022; 114 (02) 458-466
• 14 Sohn SH, Lee Y, Choi JW, Hwang HY, Kim KB. Bilateral internal thoracic artery in situ versus Y-composite graftings: long-term outcomes. Ann Thorac Surg 2020; 109 (06) 1773-1780
• 15 Deb S, Singh SK, de Souza D. et al; SUPERIOR SVG Study Investigators. SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-centre randomized control trial, NCT01047449). J Cardiothorac Surg 2019; 14 (01) 85
• 16 Akins CW, Miller DC, Turina MI. et al; STS; AATS; EACTS. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008; 85 (04) 1490-1495
• 17 Puskas JD, Sadiq A, Vassiliades TA, Kilgo PD, Lattouf OM. Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients. Ann Thorac Surg 2012; 94 (03) 710-715 , discussion 715–716
• 18 Urso S, Nogales E, González JM. et al. Bilateral internal thoracic artery versus single internal thoracic artery: a meta-analysis of propensity score-matched observational studies. Interact Cardiovasc Thorac Surg 2019; 29 (02) 163-172
• 19 Isobe N, Kaneko T, Taniguchi K, Oshima S. Comparison of the rheologic parameters in left internal thoracic artery grafts with those in saphenous vein grafts. Circ J 2005; 69 (06) 700-706
• 20 Woodward LC, Antoniades C, Taggart DP. Intraoperative vein graft preservation: what is the solution?. Ann Thorac Surg 2016; 102 (05) 1736-1746
• 21 Taggart DP, Benedetto U, Gerry S. et al; Arterial Revascularization Trial Investigators. Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med 2019; 380 (05) 437-446
• 22 Hayashi Y, Maekawa A, Sawaki S. et al. Left-sided complete revascularization with bilateral internal thoracic arteries in patients with diabetes. Ann Thorac Surg 2019; 107 (06) 1727-1735
• 23 Nakajima H, Takazawa A, Yoshitake A. et al. Intraoperative transit-time flowmetry in patients undergoing coronary surgery to determine relationships between graft flow and patency and prior coronary interventions and flow demand: a retrospective study. J Cardiothorac Surg 2018; 13 (01) 121
• 24 Taggart DP, Altman DG, Gray AM. et al; ART Investigators. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med 2016; 375 (26) 2540-2549
• 25 Hwang HY, Paeng JC, Kang J, Jang MJ, Kim KB. Relation between functional coronary artery stenosis and graft occlusion after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2021; 161 (03) 1010-1018.e1